Testing best option

The chart shows the growth of an initial investment of $10,000 in Testing best option , comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Mar 14, 2024, Testing best option 's average daily return is +0.09%, while the average monthly return is +1.73%. At this rate, an investment would double in approximately 3.4 years.

Historically, 75% of months were positive and 25% were negative. The best month was Apr 2026 with a return of +9.4%, while the worst month was Mar 2026 at -8.8%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 2 months.

On a daily basis, Testing best option closed higher 56% of trading days. The best single day was Apr 10, 2025 with a return of +6.1%, while the worst single day was Apr 4, 2025 at -5.1%.

Testing best option has an annualized alpha of 14.33%, beta of 0.36, and R2 of 0.17 versus S&P 500 Index. Calculated based on daily prices since March 14, 2024.

• This portfolio participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (90.06%) than losses (64.79%) - typical of diversified or defensive assets.
• Beta of 0.36 may look defensive, but with R2 of 0.17 this portfolio is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
• R2 of 0.17 means this portfolio moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Testing best option has an expense ratio of 0.20%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Testing best option ranks 52 for risk / return — on par with similar Portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

The current Testing best option Sharpe ratio is 2.01 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.54 to 2.41, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of Testing best option compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Testing best option . A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Testing best option was 13.80%, occurring on Apr 9, 2025. Recovery took 17 trading sessions.

The current Testing best option drawdown is 2.15%.

The chart below shows the rolling one-month volatility.